subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:16335

subject_name: Adenosine

object_name: Angina pectoris

tested_intervention: unsure


subject: CHEBI:17061

subject_name: D-Glutamine

object_name: Chemotherapeutic Agent Toxicity


subject: CHEBI:28300

subject_name: glutamine


subject: CHEBI:18050

subject_name: L-Glutamine


subject: CHEBI:140421

subject_name: Betrixaban

object_name: Thromboembolism


subject: CHEBI:6030

subject_name: Isoniazid

object_name: Diabetic foot ulcer

tested_intervention: yes


subject: UMLS:C3898761

subject_name: Ingenol Mebutate Gel

object_name: actinic cheilitis


subject: CHEBI:66964

subject_name: Dronabinol

object_name: Hair-pulling


subject: CHEBI:66964

object_name: Compulsion


subject: UMLS:C2608320

subject_name: Aspirin Low Dose

object_name: myocardial infarction


subject: UMLS:C2608320

object_name: Myocardial Infarction, CTCAE


subject: UMLS:C2608320

object_name: Myocardial Infarction by ECG Finding


subject: UMLS:C2608320

object_name: acute coronary syndrome


subject: CHEBI:135686

subject_name: Alvimopan

object_name: Fused vertebrae


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Untreated Adult Acute Myeloid Leukemia


subject: UNII:M89N0Q7EQR

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: UNII:M89N0Q7EQR

object_name: Childhood Acute Myeloid Leukemia with Minimal Differentiation


subject: UNII:M89N0Q7EQR

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: UNII:M89N0Q7EQR

object_name: Adult Acute Erythroid Leukemia


subject: UNII:M89N0Q7EQR

object_name: Adult Acute Myelomonocytic Leukemia


subject: UNII:M89N0Q7EQR

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: UNII:M89N0Q7EQR

object_name: Adult Pure Erythroid Leukemia


subject: UNII:M89N0Q7EQR

object_name: Adult Acute Basophilic Leukemia


subject: UNII:M89N0Q7EQR

object_name: adult acute monocytic leukemia


subject: UNII:M89N0Q7EQR

object_name: Adult Acute Monoblastic and Monocytic Leukemia


subject: UNII:M89N0Q7EQR

object_name: Childhood Acute Basophilic Leukemia


subject: UNII:M89N0Q7EQR

object_name: Adult Acute Monoblastic Leukemia


subject: UNII:M89N0Q7EQR

object_name: Childhood Acute Monoblastic and Monocytic Leukemia


subject: UNII:M89N0Q7EQR

object_name: Adult Acute Eosinophilic Leukemia


subject: UNII:M89N0Q7EQR

object_name: acute megakaryoblastic leukemia in adult


subject: UNII:M89N0Q7EQR

object_name: Childhood Acute Eosinophilic Leukemia


subject: UNII:M89N0Q7EQR

object_name: Adult Erythroleukemia


subject: PR:000001379

object_name: Untreated Adult Acute Myeloid Leukemia


subject: PR:000001379

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: PR:000001379

object_name: Childhood Acute Myeloid Leukemia with Minimal Differentiation


subject: PR:000001379

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: PR:000001379

object_name: Adult Acute Erythroid Leukemia


subject: PR:000001379

object_name: Adult Acute Myelomonocytic Leukemia


subject: PR:000001379

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: PR:000001379

object_name: Adult Pure Erythroid Leukemia


subject: PR:000001379

object_name: Adult Acute Basophilic Leukemia


subject: PR:000001379

object_name: adult acute monocytic leukemia


subject: PR:000001379

object_name: Adult Acute Monoblastic and Monocytic Leukemia


subject: PR:000001379

object_name: Childhood Acute Basophilic Leukemia


subject: PR:000001379

object_name: Adult Acute Monoblastic Leukemia


subject: PR:000001379

object_name: Childhood Acute Monoblastic and Monocytic Leukemia


subject: PR:000001379

object_name: Adult Acute Eosinophilic Leukemia


subject: PR:000001379

object_name: acute megakaryoblastic leukemia in adult


subject: PR:000001379

object_name: Childhood Acute Eosinophilic Leukemia


subject: PR:000001379

object_name: Adult Erythroleukemia


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:94265

subject_name: Cerubidin

object_name: adult acute myeloid leukemia with del(5q)


subject: CHEBI:94265

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: CHEBI:94265

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: CHEBI:94265

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: CHEBI:94265

object_name: Adult Acute Erythroid Leukemia


subject: CHEBI:94265


subject: CHEBI:94265


subject: CHEBI:94265


subject: CHEBI:94265


subject: CHEBI:94265


subject: CHEBI:94265


subject: CHEBI:41977

subject_name: Daunorubicin


subject: CHEBI:41977


subject: CHEBI:41977


subject: CHEBI:41977


subject: CHEBI:41977


subject: CHEBI:41977


subject: CHEBI:41977


subject: CHEBI:41977


subject: CHEBI:41977


subject: CHEBI:41977


subject: CHEBI:41977


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: untreated childhood acute myeloid leukemia and other myeloid malignancies


subject: UNII:PVI5M0M1GW

object_name: Childhood Acute Myeloid Leukemia with Minimal Differentiation


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW

object_name: Childhood Acute Myeloid Leukemia without Maturation


subject: UNII:PVI5M0M1GW

object_name: Childhood Acute Myelomonocytic Leukemia


subject: UNII:PVI5M0M1GW

object_name: childhood acute myeloid leukemia with maturation


subject: UNII:PVI5M0M1GW

object_name: Adult Acute Basophilic Leukemia


subject: UNII:PVI5M0M1GW

object_name: Adult Acute Monoblastic and Monocytic Leukemia


subject: UNII:PVI5M0M1GW

object_name: Childhood Acute Basophilic Leukemia


subject: UNII:PVI5M0M1GW

object_name: Childhood Acute Monoblastic and Monocytic Leukemia


subject: UNII:PVI5M0M1GW

object_name: childhood acute monocytic leukemia


subject: UNII:PVI5M0M1GW

object_name: Adult Acute Eosinophilic Leukemia


subject: UNII:PVI5M0M1GW

object_name: Childhood Acute Monoblastic Leukemia


subject: UNII:PVI5M0M1GW

object_name: childhood acute megakaryoblastic leukemia


subject: UNII:PVI5M0M1GW

object_name: Childhood Acute Eosinophilic Leukemia


subject: UNII:PVI5M0M1GW

object_name: Childhood Acute Erythroid Leukemia


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PUBCHEM.COMPOUND:4358571

subject_name: Valspodar

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: PUBCHEM.COMPOUND:4358571

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: PUBCHEM.COMPOUND:4358571

object_name: adult acute myeloid leukemia with del(5q)


subject: PUBCHEM.COMPOUND:4358571

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: PUBCHEM.COMPOUND:4358571

object_name: Untreated Adult Acute Myeloid Leukemia


subject: PUBCHEM.COMPOUND:4358571

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: PUBCHEM.COMPOUND:4358571

object_name: untreated childhood acute myeloid leukemia and other myeloid malignancies


subject: PUBCHEM.COMPOUND:4358571

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: PUBCHEM.COMPOUND:4358571

object_name: Childhood Acute Myeloid Leukemia with Minimal Differentiation


subject: PUBCHEM.COMPOUND:4358571

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: PUBCHEM.COMPOUND:4358571

object_name: Adult Acute Erythroid Leukemia


subject: PUBCHEM.COMPOUND:4358571

object_name: Childhood Acute Myeloid Leukemia without Maturation


subject: PUBCHEM.COMPOUND:4358571

object_name: Adult Acute Myelomonocytic Leukemia


subject: PUBCHEM.COMPOUND:4358571

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: PUBCHEM.COMPOUND:4358571

object_name: Childhood Acute Myelomonocytic Leukemia


subject: PUBCHEM.COMPOUND:4358571

object_name: Adult Pure Erythroid Leukemia


subject: PUBCHEM.COMPOUND:4358571

object_name: childhood acute myeloid leukemia with maturation


subject: PUBCHEM.COMPOUND:4358571

object_name: Adult Acute Basophilic Leukemia


subject: PUBCHEM.COMPOUND:4358571

object_name: adult acute monocytic leukemia


subject: PUBCHEM.COMPOUND:4358571

object_name: Adult Acute Monoblastic and Monocytic Leukemia


subject: PUBCHEM.COMPOUND:4358571

object_name: Childhood Acute Basophilic Leukemia


subject: PUBCHEM.COMPOUND:4358571

object_name: Adult Acute Monoblastic Leukemia


subject: PUBCHEM.COMPOUND:4358571

object_name: Childhood Acute Monoblastic and Monocytic Leukemia


subject: PUBCHEM.COMPOUND:4358571

object_name: childhood acute monocytic leukemia


subject: PUBCHEM.COMPOUND:4358571

object_name: Adult Acute Eosinophilic Leukemia


subject: PUBCHEM.COMPOUND:4358571

object_name: Childhood Acute Monoblastic Leukemia


subject: PUBCHEM.COMPOUND:4358571

object_name: acute megakaryoblastic leukemia in adult


subject: PUBCHEM.COMPOUND:4358571

object_name: childhood acute megakaryoblastic leukemia


subject: PUBCHEM.COMPOUND:4358571

object_name: Childhood Acute Eosinophilic Leukemia


subject: PUBCHEM.COMPOUND:4358571

object_name: Childhood Acute Erythroid Leukemia


subject: PUBCHEM.COMPOUND:4358571

object_name: Adult Erythroleukemia


subject: PUBCHEM.COMPOUND:4358571

object_name: childhood myelodysplastic syndrome


subject: PUBCHEM.COMPOUND:4358571

object_name: De Novo Myelodysplastic Syndrome


subject: UMLS:C0139121

subject_name: SDZ PSC 833

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: UMLS:C0139121

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: UMLS:C0139121

object_name: adult acute myeloid leukemia with del(5q)


subject: UMLS:C0139121

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: UMLS:C0139121

object_name: Untreated Adult Acute Myeloid Leukemia


subject: UMLS:C0139121

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: UMLS:C0139121

object_name: untreated childhood acute myeloid leukemia and other myeloid malignancies


subject: UMLS:C0139121

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: UMLS:C0139121

object_name: Childhood Acute Myeloid Leukemia with Minimal Differentiation


subject: UMLS:C0139121

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: UMLS:C0139121

object_name: Adult Acute Erythroid Leukemia


subject: UMLS:C0139121

object_name: Childhood Acute Myeloid Leukemia without Maturation


subject: UMLS:C0139121

object_name: Adult Acute Myelomonocytic Leukemia


subject: UMLS:C0139121

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: UMLS:C0139121

object_name: Childhood Acute Myelomonocytic Leukemia


subject: UMLS:C0139121

object_name: Adult Pure Erythroid Leukemia


subject: UMLS:C0139121

object_name: childhood acute myeloid leukemia with maturation


subject: UMLS:C0139121

object_name: Adult Acute Basophilic Leukemia


subject: UMLS:C0139121

object_name: adult acute monocytic leukemia


subject: UMLS:C0139121

object_name: Adult Acute Monoblastic and Monocytic Leukemia


subject: UMLS:C0139121

object_name: Childhood Acute Basophilic Leukemia


subject: UMLS:C0139121

object_name: Adult Acute Monoblastic Leukemia


subject: UMLS:C0139121

object_name: Childhood Acute Monoblastic and Monocytic Leukemia


subject: UMLS:C0139121

object_name: childhood acute monocytic leukemia


subject: UMLS:C0139121

object_name: Adult Acute Eosinophilic Leukemia


subject: UMLS:C0139121

object_name: Childhood Acute Monoblastic Leukemia


subject: UMLS:C0139121

object_name: acute megakaryoblastic leukemia in adult


subject: UMLS:C0139121

object_name: childhood acute megakaryoblastic leukemia


subject: UMLS:C0139121

object_name: Childhood Acute Eosinophilic Leukemia


subject: UMLS:C0139121

object_name: Childhood Acute Erythroid Leukemia


subject: UMLS:C0139121

object_name: Adult Erythroleukemia


subject: UMLS:C0139121

object_name: childhood myelodysplastic syndrome


subject: UMLS:C0139121

object_name: De Novo Myelodysplastic Syndrome


subject: CHEBI:87631

subject_name: statin

object_name: cardiovascular disorder


subject: CHEBI:95021

subject_name: pemetrexed

object_name: Recurrent ovarian cancer


subject: CHEBI:95021

object_name: Recurrent Fallopian Tube Carcinoma


subject: CHEBI:95021

object_name: Recurrent Primary Peritoneal Carcinoma


subject: UNII:PVI5M0M1GW

object_name: Metastatic Cutaneous Melanoma


subject: UNII:PVI5M0M1GW

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: UNII:PVI5M0M1GW

object_name: metastatic melanoma


subject: UNII:PVI5M0M1GW

object_name: Melanoma recurrent


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: PUBCHEM.COMPOUND:3368


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:29235

object_name: metabolic disease


subject: CHEBI:18276

subject_name: Hydrogen


subject: UMLS:C0885426

subject_name: Hydrogen, Homeopathic preparation


subject: CHEMBL.COMPOUND:CHEMBL4297766

subject_name: HYDROGEN


subject: CHEBI:151315

subject_name: Heparin

object_name: Embolic Stroke


subject: UNII:E47C0NF7LV

subject_name: ENOXAPARIN


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab

object_name: skin melanoma


subject: CHEBI:3757

subject_name: Clonidine

object_name: neurodegenerative disease


subject: CHEBI:3757

object_name: cancer


subject: CHEBI:3757

object_name: neoplasm


subject: UniProtKB:P19726

subject_name: CAPSA_BPT7 Major capsid protein (sprot)

object_name: inherited lipid metabolism disorder


subject: UniProtKB:P19726

object_name: Dyslipidemia


subject: UMLS:C3828699

subject_name: Oraxol

object_name: carcinoma of esophagus


subject: UMLS:C3828699

object_name: esophageal cancer


subject: UMLS:C3828699

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C3828699

object_name: neoplasm of esophagus


subject: UMLS:C3828699

object_name: gastroesophageal cancer


subject: UMLS:C3828699

object_name: Stomach cancer


subject: UMLS:C3828699

object_name: gastric cancer


subject: CHEBI:91899

object_name: Hyperdistention


subject: CHEBI:3207

subject_name: Budesonide


subject: UNII:A14FB57V1D

subject_name: GLYCOPYRRONIUM


subject: CHEBI:94449

subject_name: Glycopyrronium


subject: PUBCHEM.COMPOUND:9919001

subject_name: FORMOTEROL FUMARATE


subject: CHEBI:5147

subject_name: Formoterol


subject: CHEBI:408174

subject_name: Arformoterol


subject: PUBCHEM.COMPOUND:66964417

subject_name: LACTULOSE

object_name: Minimal hepatic encephalopathy


subject: UNII:9U7D5QH5AE


subject: CHEBI:7459

subject_name: Naloxone

object_name: Hypoventilation


subject: UMLS:C4329594

subject_name: CEA-MUC-1-TRICOM Vaccine CV301

object_name: pancreatic adenocarcinoma


subject: UMLS:C4329594

object_name: colorectal adenocarcinoma


subject: UMLS:C4329594

object_name: metastatic colorectal cancer


subject: UMLS:C4329594

object_name: Metastatic malignant neoplasm to pancreas


subject: CHEBI:132922

object_name: rheumatoid arthritis


subject: CHEBI:132922

object_name: osteoarthritis, hip


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: UNII:I1679X069H

subject_name: Brilacidin

object_name: cellulitis


subject: UNII:I1679X069H

object_name: skin infection


subject: UNII:I1679X069H

object_name: Skin Infection, CTCAE


subject: UNII:I1679X069H

object_name: bacterial infectious disease


subject: CHEBI:229649

subject_name: Leniolisib

object_name: common variable immunodeficiency


subject: UNII:DLG4EML025

subject_name: Secukinumab

object_name: spondyloarthropathy


subject: CHEBI:31348

subject_name: Capecitabine

object_name: cancer of unknown primary site


subject: CHEBI:31348

object_name: bile duct neoplasm


subject: CHEBI:31652

subject_name: Gimeracil

object_name: pancreatic neoplasm


subject: CHEBI:31652

object_name: exocrine pancreatic carcinoma


subject: CHEBI:31652

object_name: malignant pancreatic neoplasm


subject: CHEBI:31652

object_name: digestive system cancer


subject: CHEBI:31652


subject: CHEBI:31652


subject: UMLS:C3852659

subject_name: Teysuno


subject: UMLS:C3852659


subject: UMLS:C3852659


subject: UMLS:C3852659


subject: UMLS:C3852659


subject: UMLS:C3852659


subject: GTOPDB:8451

subject_name: demcizumab

object_name: primary peritoneal carcinoma


subject: GTOPDB:8451

object_name: papillary serous cystadenocarcinoma


subject: GTOPDB:8451

object_name: peritoneal carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2109384

subject_name: DEMCIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL2109384


subject: CHEMBL.COMPOUND:CHEMBL2109384


subject: UMLS:C2698134


subject: UMLS:C2698134


subject: UMLS:C2698134


subject: CHEBI:91594


subject: CHEBI:91594


subject: CHEBI:91594


subject: UMLS:C0678133

subject_name: Taxol


subject: UMLS:C0678133


subject: UMLS:C0678133


subject: CHEBI:84094

subject_name: testosterone sulfate

object_name: HIV wasting syndrome


subject: UMLS:C4721537

subject_name: Therapeutic Testosterone


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:9139

subject_name: Sildenafil

object_name: mild pre-eclampsia


subject: MESH:C000709231

object_name: hepatosplenic T-cell lymphoma


subject: MESH:C000709231

object_name: enteropathy-associated T-cell lymphoma


subject: MESH:C000709231

object_name: extranodal nasal NK/T cell lymphoma


subject: MESH:C000709231

object_name: adult nasal type extranodal NK/T-cell lymphoma


subject: MESH:C000709231

object_name: childhood nasal type extranodal NK/T-cell lymphoma


subject: MESH:C000709231

object_name: adult T-cell leukemia/lymphoma


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: PUBCHEM.COMPOUND:58008990

subject_name: Duvelisib


subject: PUBCHEM.COMPOUND:58008990


subject: PUBCHEM.COMPOUND:58008990


subject: PUBCHEM.COMPOUND:58008990


subject: PUBCHEM.COMPOUND:58008990


subject: PUBCHEM.COMPOUND:58008990


subject: CHEBI:61080

subject_name: Romidepsin


subject: CHEBI:61080


subject: CHEBI:61080


subject: CHEBI:61080


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: CHEBI:8404

subject_name: Prilocaine

object_name: premature ejaculation


subject: MESH:C000723595

object_name: irritable bowel syndrome


subject: DRUGBANK:DB10418

subject_name: Blatella germanica

object_name: Persistent asthma


subject: UMLS:C4723424

subject_name: Plenvu

object_name: polyp of colon


subject: UMLS:C4723424

object_name: colorectal cancer


subject: UMLS:C4723424

object_name: colorectal carcinoma


subject: UMLS:C4723424

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:31401

subject_name: Cilostazol

object_name: brain aneurysm


subject: CHEBI:37941

subject_name: Clopidogrel


subject: CHEBI:87715

subject_name: Prasugrel


subject: CHEBI:76989

subject_name: phytoestrogen

object_name: Low serum lipid levels


subject: UMLS:C5960320

subject_name: Wnt Signaling Inhibitor APL-5125


subject: UMLS:C5960320


subject: UMLS:C5960320


subject: UMLS:C5960320

object_name: cholangiocarcinoma


subject: UMLS:C5960320

object_name: pancreatic adenocarcinoma


subject: UMLS:C5960320

object_name: gastric adenocarcinoma


subject: UMLS:C5960320

object_name: endometrium adenocarcinoma


subject: UMLS:C5960320

object_name: appendix adenocarcinoma


subject: UMLS:C5960320

object_name: triple-negative breast carcinoma


subject: UMLS:C5960320

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C5960320

object_name: prostate carcinoma


subject: UMLS:C5960320

object_name: prostate cancer


subject: UMLS:C5960320

object_name: ovarian cancer


subject: UMLS:C5960320

object_name: ovarian neoplasm


subject: UMLS:C5960320

object_name: ovarian carcinoma


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Ovarian Sex Cord Tumor with Annular Tubules


subject: UNII:2S9ZZM9Q9V

object_name: Ovarian Steroid Cell Tumor


subject: UNII:2S9ZZM9Q9V

object_name: ovarian Sertoli-Leydig cell tumor


subject: UNII:2S9ZZM9Q9V

object_name: ovarian granulosa cell tumor


subject: UNII:2S9ZZM9Q9V

object_name: Adult Type Ovarian Granulosa Cell Tumor


subject: UNII:2S9ZZM9Q9V

object_name: ovarian gynandroblastoma


subject: CHEBI:59773

subject_name: CROMOLYN

object_name: Ischemic stroke


subject: UNII:XX2BGT8CLL

subject_name: BRIVEKIMIG

object_name: Acne inversa


subject: UMLS:C5960042

subject_name: Brivekimig


subject: CHEBI:16586

subject_name: Aminocaproic acid

object_name: osteoarthritis


subject: UMLS:C2985200

object_name: prostate neoplasm


subject: CHEBI:8485

subject_name: Proparacaine

object_name: anisocoria


subject: CHEBI:9757

subject_name: Tropicamide


subject: CHEBI:75922

subject_name: Nepafenac

object_name: Macular thickening


subject: UMLS:C0728976

subject_name: Control brand of phenylpropanolamine

object_name: Immune Tolerance


subject: UMLS:C0308718

subject_name: CONTROL veterinary product


subject: UMLS:C1550141

subject_name: control substance


subject: UMLS:C0876134

subject_name: Prevnar


subject: CHEBI:53261

subject_name: poly(p-phenylenevinylene) macromolecule


subject: CHEBI:60581

subject_name: poly(p-phenylenevinylene) polymer


subject: UMLS:C5907902

object_name: plasma cell myeloma


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Pleural mesothelioma malignant advanced


subject: UMLS:C2347419

object_name: Solid Neoplasm


subject: CHEBI:133023

subject_name: Lifitegrast

object_name: glaucoma


subject: CHEBI:133023

object_name: Glaucoma, CTCAE


subject: CHEBI:133023

object_name: Ocular surface disease


subject: CHEBI:133023

object_name: Ocular Surface Disease, CTCAE


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: abortion in first trimester


subject: CHEBI:52172

subject_name: Nilotinib

object_name: digestive system cancer


subject: CHEBI:72292

subject_name: Bedaquiline

object_name: leprosy


subject: UMLS:C5447313

subject_name: IRE1 RNase Inhibitor ORIN1001

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5447313

object_name: Carcinoma breast stage IV


subject: CHEMBL.COMPOUND:CHEMBL2108924

subject_name: CINNAMON

object_name: Normal weight


subject: CHEMBL.COMPOUND:CHEMBL2108924

object_name: Overweight and obesity


subject: UMLS:C0939899

subject_name: cinnamon preparation


subject: UMLS:C0939899


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C4053601


subject: CHEBI:42797

subject_name: Gabapentin

object_name: vasomotor symptom


subject: CHEBI:61606


subject: CHEBI:61606

object_name: pharyngitis


subject: CHEBI:61606

object_name: Pharyngalgia


subject: CHEBI:61606

object_name: Sore Throat, CTCAE


subject: CHEBI:61606

object_name: Cough


subject: CHEBI:61606

object_name: Cough, CTCAE


subject: CHEBI:61606

object_name: Dyspnea


subject: CHEBI:61606

object_name: Abdominal pain


subject: CHEBI:61606

object_name: Chest pain


subject: CHEBI:61606

object_name: Paresis


subject: CHEBI:61606

object_name: Muscle weakness


subject: CHEBI:61606

object_name: Irritability


subject: CHEBI:61606

object_name: Myalgia


subject: CHEBI:61606

object_name: Arthralgia


subject: CHEBI:61606

object_name: Confusion, CTCAE 3.0


subject: CHEBI:61606

object_name: Bewilderment


subject: CHEBI:61606

object_name: Confusion, CTCAE 5.0


subject: CHEBI:61606

object_name: Confusion


subject: CHEBI:61606

object_name: Vomiting, CTCAE


subject: CHEBI:61606

object_name: Vomiting


subject: CHEBI:61606

object_name: Headache


subject: CHEBI:61606

object_name: Headache, CTCAE


subject: CHEBI:61606

object_name: anosmia


subject: CHEBI:61606

object_name: Anosmia, CTCAE


subject: CHEBI:61606

object_name: Nausea, CTCAE_5


subject: CHEBI:61606

object_name: Nausea


subject: CHEBI:61606

object_name: Nausea, CTCAE_3


subject: CHEBI:61606

object_name: Fever


subject: CHEBI:61606

object_name: Fever symptoms (finding)


subject: CHEBI:61606

object_name: Fever, CTCAE


subject: PUBCHEM.COMPOUND:53477767

subject_name: Hesperidin


subject: PUBCHEM.COMPOUND:53477767

object_name: pharyngitis


subject: PUBCHEM.COMPOUND:53477767

object_name: Pharyngalgia


subject: PUBCHEM.COMPOUND:53477767

object_name: Sore Throat, CTCAE


subject: PUBCHEM.COMPOUND:53477767

object_name: Cough


subject: PUBCHEM.COMPOUND:53477767

object_name: Cough, CTCAE


subject: PUBCHEM.COMPOUND:53477767

object_name: Dyspnea


subject: PUBCHEM.COMPOUND:53477767

object_name: Abdominal pain


subject: PUBCHEM.COMPOUND:53477767

object_name: Chest pain


subject: PUBCHEM.COMPOUND:53477767

object_name: Paresis


subject: PUBCHEM.COMPOUND:53477767

object_name: Muscle weakness


subject: PUBCHEM.COMPOUND:53477767

object_name: Irritability


subject: PUBCHEM.COMPOUND:53477767

object_name: Myalgia


subject: PUBCHEM.COMPOUND:53477767

object_name: Arthralgia


subject: PUBCHEM.COMPOUND:53477767

object_name: Confusion, CTCAE 3.0


subject: PUBCHEM.COMPOUND:53477767

object_name: Bewilderment


subject: PUBCHEM.COMPOUND:53477767

object_name: Confusion, CTCAE 5.0


subject: PUBCHEM.COMPOUND:53477767

object_name: Confusion


subject: PUBCHEM.COMPOUND:53477767

object_name: Vomiting, CTCAE


subject: PUBCHEM.COMPOUND:53477767

object_name: Vomiting


subject: PUBCHEM.COMPOUND:53477767

object_name: Headache


subject: PUBCHEM.COMPOUND:53477767

object_name: Headache, CTCAE


subject: PUBCHEM.COMPOUND:53477767

object_name: anosmia


subject: PUBCHEM.COMPOUND:53477767

object_name: Anosmia, CTCAE


subject: PUBCHEM.COMPOUND:53477767

object_name: Nausea, CTCAE_5


subject: PUBCHEM.COMPOUND:53477767

object_name: Nausea


subject: PUBCHEM.COMPOUND:53477767

object_name: Nausea, CTCAE_3


subject: PUBCHEM.COMPOUND:53477767

object_name: Fever


subject: PUBCHEM.COMPOUND:53477767

object_name: Fever symptoms (finding)


subject: PUBCHEM.COMPOUND:53477767

object_name: Fever, CTCAE


subject: UNII:3C6FZ6UXC8

subject_name: JDTIC

object_name: cocaine dependence


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex

object_name: Postoperative atelectasis


subject: PUBCHEM.COMPOUND:74030550

object_name: abnormal; pulmonary function, newborn


subject: UNII:513P80B4YJ

subject_name: Avapritinib

object_name: systemic mastocytosis


subject: UNII:513P80B4YJ

object_name: aggressive systemic mastocytosis


subject: UNII:513P80B4YJ

object_name: mast cell leukemia


subject: CHEBI:47458

subject_name: Saracatinib

object_name: Childhood Breast Carcinoma


subject: CHEBI:47458

object_name: breast carcinoma


subject: CHEBI:47458

object_name: breast cancer


subject: CHEBI:47458

object_name: prostate carcinoma


subject: CHEBI:47458

object_name: prostate cancer


subject: CHEBI:47458

object_name: bone cancer


subject: CHEBI:47458

object_name: bone neoplasm


subject: UMLS:C1706679


subject: UMLS:C1706679


subject: UMLS:C1706679


subject: UMLS:C1706679


subject: UMLS:C1706679


subject: UMLS:C1706679


subject: UMLS:C1706679


subject: CHEBI:2549

subject_name: Albuterol

object_name: congenital myasthenic syndrome


subject: UNII:7D0YB67S97

subject_name: Abatacept

object_name: IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY


subject: UNII:7D0YB67S97

object_name: autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency


subject: CHEBI:91899

object_name: status asthmaticus


subject: CHEBI:91899

object_name: Acute severe refractory exacerbation of asthma


subject: CHEBI:3207

subject_name: Budesonide


subject: CHEBI:3207


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: Neoplasm Metastasis


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: PR:000005628

subject_name: beta-Ala-His dipeptidase

object_name: Advanced Malignant Solid Neoplasm


subject: PR:000005628

object_name: B-cell neoplasm


subject: PUBCHEM.COMPOUND:1972

subject_name: Fungizone

object_name: Invasive fungal infection


subject: PUBCHEM.COMPOUND:1972

object_name: Febrile Neutropenia


subject: UMLS:C5854339


subject: UMLS:C5854339


subject: PR:000007168

subject_name: DNA excision repair protein ERCC-6

object_name: Nutritional status


subject: UMLS:C2983764

object_name: Advanced Hepatocellular Carcinoma


subject: GTOPDB:8089

subject_name: bermekimab

object_name: atopic eczema


subject: CHEMBL.COMPOUND:CHEMBL2109653

subject_name: BERMEKIMAB


subject: UMLS:C2981842


subject: CHEBI:32296

subject_name: vinorelbine L-tartrate

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:32296

object_name: Non-small cell lung cancer recurrent


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: CHEBI:53750

subject_name: vinorelbine D-tartrate


subject: CHEBI:53750


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine


subject: CHEBI:93786


subject: UMLS:C0378248

subject_name: Typhim VI

object_name: endogenous depression


subject: UMLS:C0378248

object_name: major depressive disorder


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam

object_name: Pregnant


subject: UNII:0Y70779M1F

subject_name: Botulinum toxin type B

object_name: Acne inversa


subject: UMLS:C0006051


subject: CHEBI:71219

subject_name: Pazopanib

object_name: stage IVA follicular thyroid cancer


subject: CHEBI:71219

object_name: stage IVC follicular thyroid cancer


subject: CHEBI:71219

object_name: stage IVB follicular thyroid cancer


subject: CHEBI:71219

object_name: stage IVB papillary thyroid cancer


subject: CHEBI:71219

object_name: stage IVC papillary thyroid cancer


subject: CHEBI:71219

object_name: stage IVA papillary thyroid cancer


subject: PUBCHEM.COMPOUND:118627280

object_name: Childhood Solid Neoplasm


subject: PUBCHEM.COMPOUND:118627280

object_name: Adult Solid Neoplasm


subject: PUBCHEM.COMPOUND:118627280

object_name: Solid Neoplasm


subject: UMLS:C5237309


subject: UMLS:C5237309


subject: UMLS:C5237309


subject: CHEBI:91400

subject_name: Afatinib

object_name: urothelial carcinoma


subject: CHEBI:91400

object_name: transitional cell carcinoma


subject: CHEBI:90225

subject_name: Rubitecan

object_name: skin melanoma


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: MALT lymphoma


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: CHEBI:36080

subject_name: protein

object_name: Community-Acquired Pneumonia


subject: UMLS:C0033684

subject_name: Proteins


subject: PR:000000001


subject: UMLS:C0302837

subject_name: Vitamin supplementation


subject: UMLS:C0007507

subject_name: Antigens, CD25

object_name: type 1 diabetes mellitus 1


subject: UMLS:C0007507

object_name: type 1 diabetes mellitus


subject: PR:000001380

subject_name: interleukin-2 receptor subunit alpha


subject: PR:000001380


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: Cancer of lung stage II


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: CHEBI:33364

subject_name: Platinum


subject: CHEMBL.COMPOUND:CHEMBL1235478

subject_name: PLATINUM


subject: UMLS:C1171558

subject_name: Platinum metallicum, platinum, Homeopathic preparation


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: childhood neoplasm


subject: UNII:PQX0D8J21J

object_name: neoplastic syndrome


subject: UNII:PQX0D8J21J

object_name: cancer or benign tumor


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: CHEBI:230570

object_name: Burn injury


subject: CHEBI:135047

subject_name: Phenyltoloxamine

object_name: asthma


subject: PR:000010988

subject_name: cytosolic iron-sulfur assembly component 3


subject: UniProtKB:P14283

subject_name: PERT_BORPE Pertactin autotransporter (sprot)


subject: UMLS:C2983787

subject_name: STAT3 Inhibitor OPB-31121


subject: UMLS:C2983787


subject: UMLS:C2983787


subject: UMLS:C2983787

object_name: Advanced cancer


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Cardiovascular morbidity


subject: PUBCHEM.COMPOUND:3062

subject_name: Cogoxin

object_name: Acute Heart Failure Related to COVID-19


subject: PUBCHEM.COMPOUND:3062

object_name: Acute heart failure


subject: CHEBI:145795


subject: CHEBI:145795


subject: CHEBI:4551

subject_name: Digoxin


subject: CHEBI:4551


subject: CHEBI:47381

subject_name: Diclofenac

object_name: Post-ERCP acute pancreatitis


subject: CHEBI:17553

object_name: Childhood Solid Neoplasm


subject: CHEBI:17553

object_name: Adult Solid Neoplasm


subject: CHEBI:17553

object_name: Solid Neoplasm


subject: CHEBI:58190


subject: CHEBI:58190


subject: CHEBI:58190


subject: CHEBI:16038

subject_name: phosphatidylethanolamine


subject: CHEBI:16038


subject: CHEBI:16038


subject: CHEBI:36711

subject_name: phosphoethanolamine


subject: CHEBI:36711


subject: CHEBI:36711


subject: UMLS:C3273718

subject_name: Maveropepimut-S

object_name: Childhood Breast Carcinoma


subject: UMLS:C3273718

object_name: breast carcinoma


subject: UMLS:C3273718

object_name: breast cancer


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: osteogenesis imperfecta


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: Childhood Acute Erythroid Leukemia


subject: PUBCHEM.COMPOUND:1805

object_name: erythroleukemia


subject: PUBCHEM.COMPOUND:1805

object_name: Adult Acute Erythroid Leukemia


subject: PUBCHEM.COMPOUND:1805

object_name: childhood acute megakaryoblastic leukemia


subject: PUBCHEM.COMPOUND:1805

object_name: acute megakaryoblastic leukemia


subject: PUBCHEM.COMPOUND:1805

object_name: Myelodysplastic syndrome with low blasts (disorder)


subject: PUBCHEM.COMPOUND:1805

object_name: myelodysplastic syndrome with single lineage dysplasia


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:45716

subject_name: Vorinostat


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:3127

subject_name: Bisoprolol

object_name: Heart Failure, CTCAE


subject: UNII:W530IRZ40G

object_name: Hepatic impairment


subject: CHEBI:16236

subject_name: Ethanol

object_name: Thyroid nodule


subject: CHEBI:16236

object_name: nodule of thyroid by palpation


subject: CHEBI:64312

subject_name: Memantine

object_name: generalized anxiety disorder


subject: UNII:M67G28K74K

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: UNII:M67G28K74K

object_name: peripheral T-cell lymphoma, not otherwise specified


subject: UNII:M67G28K74K

object_name: Advanced cancer


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Treatment related acute myeloid leukaemia


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: RXCUI:606051

subject_name: ProQuad

object_name: heart disorder


subject: RXCUI:606051

object_name: acute liver failure


subject: RXCUI:606051

object_name: Chronic uremia


subject: CHEBI:94463

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:63580

subject_name: Ribavirin


subject: CHEBI:7852

subject_name: Oxycodone

object_name: cancer pain


subject: CHEBI:16412

subject_name: Lysophosphotidylserine

object_name: asthma


subject: CHEBI:16412

object_name: Asthmatic pulmonary eosinophilia


subject: UMLS:C5666962

subject_name: Anti-LAG-3 Monoclonal Antibody HLX26

object_name: metastatic colorectal cancer


subject: CHEBI:93763

object_name: Advanced breast cancer


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Recurrent lung cancer


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3367

object_name: Secondary malignant neoplasm of lung


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: PR:000001151

subject_name: Toll-like receptor 1

object_name: lung cancer


subject: PR:000001151

object_name: lung neoplasm


subject: PR:000001151

object_name: lung carcinoma


subject: PR:000001151


subject: PR:000001151


subject: PR:000001151

object_name: non-small cell lung carcinoma


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Alzheimer disease type 1


subject: CHEBI:85078

object_name: Alzheimer disease


subject: CHEBI:44423

subject_name: Hydroxyurea

object_name: fibromatosis


subject: UNII:CEGM9YBNGD

subject_name: Selpercatinib

object_name: Childhood Solid Neoplasm


subject: UNII:CEGM9YBNGD

object_name: Adult Solid Neoplasm


subject: UNII:CEGM9YBNGD

object_name: Solid Neoplasm


subject: CHEBI:63631

subject_name: Topiramate

object_name: hypertension


subject: CHEBI:63631

object_name: Hypertension, CTCAE


subject: UMLS:C4305639


subject: CHEBI:94793

subject_name: Pimasertib

object_name: acute myeloid leukemia


subject: CHEBI:94793

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:48828

object_name: Tabagism


subject: GTOPDB:9531

subject_name: CO


subject: CHEBI:27638

subject_name: Cobalt


subject: CHEBI:17245

subject_name: Carbon monoxide


subject: CHEBI:12777

subject_name: Vitamin A

object_name: asthma


subject: PUBCHEM.COMPOUND:2767

object_name: Metastatic Colorectal Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Metastatic Gastric Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IV Colorectal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVB Colorectal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVC Colorectal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVA Colorectal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IV Ovarian Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Clinical Stage IVA Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Clinical Stage IVB Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Pathologic Stage IV Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Metastatic Appendix Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IV Appendix Carcinoma AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVB Appendix Carcinoma AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVA Appendix Carcinoma AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVC Appendix Carcinoma AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IV Uterine Corpus Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVA Uterine Corpus Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVB Uterine Corpus Cancer AJCC v8


subject: CHEBI:64816

object_name: Metastatic Colorectal Carcinoma


subject: CHEBI:64816

object_name: Metastatic Gastric Carcinoma


subject: CHEBI:64816

object_name: Stage IV Colorectal Cancer AJCC v8


subject: CHEBI:64816

object_name: Stage IVB Colorectal Cancer AJCC v8


subject: CHEBI:64816

object_name: Stage IVC Colorectal Cancer AJCC v8


subject: CHEBI:64816

object_name: Stage IVA Colorectal Cancer AJCC v8


subject: CHEBI:64816

object_name: Stage IV Ovarian Carcinoma


subject: CHEBI:64816

object_name: Clinical Stage IV Gastric Cancer AJCC v8


subject: CHEBI:64816

object_name: Clinical Stage IVA Gastric Cancer AJCC v8


subject: CHEBI:64816

object_name: Clinical Stage IVB Gastric Cancer AJCC v8


subject: CHEBI:64816

object_name: Stage IV Ovarian Cancer AJCC v8


subject: CHEBI:64816

object_name: Stage IVA Ovarian Cancer AJCC v8


subject: CHEBI:64816

object_name: Stage IVB Ovarian Cancer AJCC v8


subject: CHEBI:64816

object_name: Pathologic Stage IV Gastric Cancer AJCC v8


subject: CHEBI:64816

object_name: Metastatic Appendix Carcinoma


subject: CHEBI:64816

object_name: Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8


subject: CHEBI:64816

object_name: Stage IV Appendix Carcinoma AJCC v8


subject: CHEBI:64816

object_name: Stage IVB Appendix Carcinoma AJCC v8


subject: CHEBI:64816

object_name: Stage IVA Appendix Carcinoma AJCC v8


subject: CHEBI:64816

object_name: Stage IVC Appendix Carcinoma AJCC v8


subject: CHEBI:64816

object_name: Stage IV Uterine Corpus Cancer AJCC v8


subject: CHEBI:64816

object_name: Stage IVA Uterine Corpus Cancer AJCC v8


subject: CHEBI:64816

object_name: Stage IVB Uterine Corpus Cancer AJCC v8


subject: CHEBI:64816

object_name: uterine cancer


subject: CHEBI:91872

object_name: Metastatic Colorectal Carcinoma


subject: CHEBI:91872

object_name: Metastatic Gastric Carcinoma


subject: CHEBI:91872

object_name: Stage IV Colorectal Cancer AJCC v8


subject: CHEBI:91872

object_name: Stage IVB Colorectal Cancer AJCC v8


subject: CHEBI:91872

object_name: Stage IVC Colorectal Cancer AJCC v8


subject: CHEBI:91872

object_name: Stage IVA Colorectal Cancer AJCC v8


subject: CHEBI:91872

object_name: Stage IV Ovarian Carcinoma


subject: CHEBI:91872

object_name: Clinical Stage IV Gastric Cancer AJCC v8


subject: CHEBI:91872

object_name: Clinical Stage IVA Gastric Cancer AJCC v8


subject: CHEBI:91872

object_name: Clinical Stage IVB Gastric Cancer AJCC v8


subject: CHEBI:91872

object_name: Stage IV Ovarian Cancer AJCC v8


subject: CHEBI:91872

object_name: Stage IVA Ovarian Cancer AJCC v8


subject: CHEBI:91872

object_name: Stage IVB Ovarian Cancer AJCC v8


subject: CHEBI:91872

object_name: Pathologic Stage IV Gastric Cancer AJCC v8


subject: CHEBI:91872

object_name: Metastatic Appendix Carcinoma


subject: CHEBI:91872

object_name: Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8


subject: CHEBI:91872

object_name: Stage IV Appendix Carcinoma AJCC v8


subject: CHEBI:91872

object_name: Stage IVB Appendix Carcinoma AJCC v8


subject: CHEBI:91872

object_name: Stage IVA Appendix Carcinoma AJCC v8


subject: CHEBI:91872

object_name: Stage IVC Appendix Carcinoma AJCC v8


subject: CHEBI:91872

object_name: Stage IV Uterine Corpus Cancer AJCC v8


subject: CHEBI:91872

object_name: Stage IVA Uterine Corpus Cancer AJCC v8


subject: CHEBI:91872

object_name: Stage IVB Uterine Corpus Cancer AJCC v8


subject: CHEBI:91872

object_name: uterine cancer


subject: CHEBI:28748

subject_name: Doxorubicin

object_name: Metastatic Colorectal Carcinoma


subject: CHEBI:28748

object_name: Metastatic Gastric Carcinoma


subject: CHEBI:28748

object_name: Stage IV Colorectal Cancer AJCC v8


subject: CHEBI:28748

object_name: Stage IVB Colorectal Cancer AJCC v8


subject: CHEBI:28748

object_name: Stage IVC Colorectal Cancer AJCC v8


subject: CHEBI:28748

object_name: Stage IVA Colorectal Cancer AJCC v8


subject: CHEBI:28748

object_name: Stage IV Ovarian Carcinoma


subject: CHEBI:28748

object_name: Clinical Stage IV Gastric Cancer AJCC v8


subject: CHEBI:28748

object_name: Clinical Stage IVA Gastric Cancer AJCC v8


subject: CHEBI:28748

object_name: Clinical Stage IVB Gastric Cancer AJCC v8


subject: CHEBI:28748

object_name: Stage IVA Ovarian Cancer AJCC v8


subject: CHEBI:28748

object_name: Stage IVB Ovarian Cancer AJCC v8


subject: CHEBI:28748

object_name: Pathologic Stage IV Gastric Cancer AJCC v8


subject: CHEBI:28748

object_name: Metastatic Appendix Carcinoma


subject: CHEBI:28748

object_name: Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8


subject: CHEBI:28748

object_name: Stage IV Appendix Carcinoma AJCC v8


subject: CHEBI:28748

object_name: Stage IVB Appendix Carcinoma AJCC v8


subject: CHEBI:28748

object_name: Stage IVA Appendix Carcinoma AJCC v8


subject: CHEBI:28748

object_name: Stage IVC Appendix Carcinoma AJCC v8


subject: CHEBI:28748

object_name: Stage IV Uterine Corpus Cancer AJCC v8


subject: CHEBI:28748

object_name: Stage IVA Uterine Corpus Cancer AJCC v8


subject: CHEBI:28748

object_name: Stage IVB Uterine Corpus Cancer AJCC v8


subject: CHEBI:28748

object_name: uterine cancer


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:8988

object_name: peritoneal carcinomatosis


subject: CHEBI:8988

object_name: Stage IV Ovarian Carcinoma


subject: CHEBI:8988

object_name: Clinical Stage IVA Gastric Cancer AJCC v8


subject: CHEBI:8988

object_name: Clinical Stage IVB Gastric Cancer AJCC v8


subject: CHEBI:8988

object_name: Stage IVA Ovarian Cancer AJCC v8


subject: CHEBI:8988

object_name: Stage IVB Ovarian Cancer AJCC v8


subject: CHEBI:8988

object_name: Pathologic Stage IV Gastric Cancer AJCC v8


subject: CHEBI:8988

object_name: Metastatic Appendix Carcinoma


subject: CHEBI:8988

object_name: Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8


subject: CHEBI:8988

object_name: Stage IV Appendix Carcinoma AJCC v8


subject: CHEBI:8988

object_name: Stage IVB Appendix Carcinoma AJCC v8


subject: CHEBI:8988

object_name: Stage IVA Appendix Carcinoma AJCC v8


subject: CHEBI:8988

object_name: Stage IVC Appendix Carcinoma AJCC v8


subject: CHEBI:8988

object_name: Stage IV Uterine Corpus Cancer AJCC v8


subject: CHEBI:8988

object_name: Stage IVA Uterine Corpus Cancer AJCC v8


subject: CHEBI:8988

object_name: Stage IVB Uterine Corpus Cancer AJCC v8


subject: CHEBI:8988

object_name: uterine cancer


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid

object_name: Metastatic Gastric Carcinoma


subject: CHEBI:191174

object_name: Stage IV Ovarian Carcinoma


subject: CHEBI:191174

object_name: Clinical Stage IV Gastric Cancer AJCC v8


subject: CHEBI:191174

object_name: Clinical Stage IVA Gastric Cancer AJCC v8


subject: CHEBI:191174

object_name: Clinical Stage IVB Gastric Cancer AJCC v8


subject: CHEBI:191174

object_name: Stage IV Ovarian Cancer AJCC v8


subject: CHEBI:191174

object_name: Stage IVA Ovarian Cancer AJCC v8


subject: CHEBI:191174

object_name: Stage IVB Ovarian Cancer AJCC v8


subject: CHEBI:191174

object_name: Pathologic Stage IV Gastric Cancer AJCC v8


subject: CHEBI:191174

object_name: Metastatic Appendix Carcinoma


subject: CHEBI:191174

object_name: Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8


subject: CHEBI:191174

object_name: Stage IV Appendix Carcinoma AJCC v8


subject: CHEBI:191174

object_name: Stage IVB Appendix Carcinoma AJCC v8


subject: CHEBI:191174

object_name: Stage IVA Appendix Carcinoma AJCC v8


subject: CHEBI:191174

object_name: Stage IVC Appendix Carcinoma AJCC v8


subject: CHEBI:191174

object_name: Stage IV Uterine Corpus Cancer AJCC v8


subject: CHEBI:191174

object_name: Stage IVA Uterine Corpus Cancer AJCC v8


subject: CHEBI:191174

object_name: Stage IVB Uterine Corpus Cancer AJCC v8


subject: CHEBI:191174

object_name: Metastatic malignant neoplasm to peritoneum


subject: CHEBI:191174

object_name: uterine cancer


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid

object_name: Metastatic Gastric Carcinoma


subject: PUBCHEM.COMPOUND:135402009

object_name: Stage IV Ovarian Carcinoma


subject: PUBCHEM.COMPOUND:135402009

object_name: Clinical Stage IV Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135402009

object_name: Clinical Stage IVA Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135402009

object_name: Clinical Stage IVB Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135402009

object_name: Stage IV Ovarian Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135402009

object_name: Stage IVA Ovarian Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135402009

object_name: Stage IVB Ovarian Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135402009

object_name: Pathologic Stage IV Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135402009

object_name: Metastatic Appendix Carcinoma


subject: PUBCHEM.COMPOUND:135402009

object_name: Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135402009

object_name: Stage IV Appendix Carcinoma AJCC v8


subject: PUBCHEM.COMPOUND:135402009

object_name: Stage IVB Appendix Carcinoma AJCC v8


subject: PUBCHEM.COMPOUND:135402009

object_name: Stage IVA Appendix Carcinoma AJCC v8


subject: PUBCHEM.COMPOUND:135402009

object_name: Stage IVC Appendix Carcinoma AJCC v8


subject: PUBCHEM.COMPOUND:135402009

object_name: Stage IV Uterine Corpus Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135402009

object_name: Stage IVA Uterine Corpus Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135402009

object_name: Stage IVB Uterine Corpus Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135402009

object_name: Metastatic malignant neoplasm to peritoneum


subject: CHEBI:15640

subject_name: Leucovorin

object_name: Stage IV Ovarian Carcinoma


subject: CHEBI:15640

object_name: Clinical Stage IVA Gastric Cancer AJCC v8


subject: CHEBI:15640

object_name: Clinical Stage IVB Gastric Cancer AJCC v8


subject: CHEBI:15640

object_name: Stage IV Ovarian Cancer AJCC v8


subject: CHEBI:15640

object_name: Stage IVA Ovarian Cancer AJCC v8


subject: CHEBI:15640

object_name: Stage IVB Ovarian Cancer AJCC v8


subject: CHEBI:15640

object_name: Pathologic Stage IV Gastric Cancer AJCC v8


subject: CHEBI:15640

object_name: Metastatic Appendix Carcinoma


subject: CHEBI:15640

object_name: Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8


subject: CHEBI:15640

object_name: Stage IV Appendix Carcinoma AJCC v8


subject: CHEBI:15640

object_name: Stage IVB Appendix Carcinoma AJCC v8


subject: CHEBI:15640

object_name: Stage IVA Appendix Carcinoma AJCC v8


subject: CHEBI:15640

object_name: Stage IVC Appendix Carcinoma AJCC v8


subject: CHEBI:15640

object_name: Stage IV Uterine Corpus Cancer AJCC v8


subject: CHEBI:15640

object_name: Stage IVA Uterine Corpus Cancer AJCC v8


subject: CHEBI:15640

object_name: Stage IVB Uterine Corpus Cancer AJCC v8


subject: CHEBI:63606

subject_name: Levoleucovorin

object_name: Metastatic Gastric Carcinoma


subject: CHEBI:63606

object_name: Stage IV Ovarian Carcinoma


subject: CHEBI:63606

object_name: Clinical Stage IV Gastric Cancer AJCC v8


subject: CHEBI:63606

object_name: Clinical Stage IVA Gastric Cancer AJCC v8


subject: CHEBI:63606

object_name: Clinical Stage IVB Gastric Cancer AJCC v8


subject: CHEBI:63606

object_name: Stage IV Ovarian Cancer AJCC v8


subject: CHEBI:63606

object_name: Stage IVA Ovarian Cancer AJCC v8


subject: CHEBI:63606

object_name: Stage IVB Ovarian Cancer AJCC v8


subject: CHEBI:63606

object_name: Pathologic Stage IV Gastric Cancer AJCC v8


subject: CHEBI:63606

object_name: Metastatic Appendix Carcinoma


subject: CHEBI:63606

object_name: Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8


subject: CHEBI:63606

object_name: Stage IV Appendix Carcinoma AJCC v8


subject: CHEBI:63606

object_name: Stage IVB Appendix Carcinoma AJCC v8


subject: CHEBI:63606

object_name: Stage IVA Appendix Carcinoma AJCC v8


subject: CHEBI:63606

object_name: Stage IVC Appendix Carcinoma AJCC v8


subject: CHEBI:63606

object_name: Stage IV Uterine Corpus Cancer AJCC v8


subject: CHEBI:63606

object_name: Stage IVA Uterine Corpus Cancer AJCC v8


subject: CHEBI:63606

object_name: Stage IVB Uterine Corpus Cancer AJCC v8


subject: CHEBI:63606

object_name: Metastatic malignant neoplasm to peritoneum


subject: CHEBI:25357

subject_name: mitomycin

object_name: Metastatic Gastric Carcinoma


subject: CHEBI:25357

object_name: Stage IV Colorectal Cancer AJCC v8


subject: CHEBI:25357

object_name: Stage IVB Colorectal Cancer AJCC v8


subject: CHEBI:25357

object_name: Stage IVA Colorectal Cancer AJCC v8


subject: CHEBI:25357

object_name: Stage IV Ovarian Carcinoma


subject: CHEBI:25357

object_name: Clinical Stage IV Gastric Cancer AJCC v8


subject: CHEBI:25357

object_name: Clinical Stage IVA Gastric Cancer AJCC v8


subject: CHEBI:25357

object_name: Clinical Stage IVB Gastric Cancer AJCC v8


subject: CHEBI:25357

object_name: Stage IV Ovarian Cancer AJCC v8


subject: CHEBI:25357

object_name: Stage IVA Ovarian Cancer AJCC v8


subject: CHEBI:25357

object_name: Stage IVB Ovarian Cancer AJCC v8


subject: CHEBI:25357

object_name: Pathologic Stage IV Gastric Cancer AJCC v8


subject: CHEBI:25357

object_name: Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8


subject: CHEBI:25357

object_name: Stage IVB Appendix Carcinoma AJCC v8


subject: CHEBI:25357

object_name: Stage IVA Appendix Carcinoma AJCC v8


subject: CHEBI:25357

object_name: Stage IVC Appendix Carcinoma AJCC v8


subject: CHEBI:25357

object_name: Stage IV Uterine Corpus Cancer AJCC v8


subject: CHEBI:25357

object_name: Stage IVA Uterine Corpus Cancer AJCC v8


subject: CHEBI:25357

object_name: Stage IVB Uterine Corpus Cancer AJCC v8


subject: CHEBI:25357

object_name: uterine cancer


subject: CHEBI:25357

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:27504

subject_name: Mitomycin

object_name: Metastatic Gastric Carcinoma


subject: CHEBI:27504

object_name: Stage IV Colorectal Cancer AJCC v8


subject: CHEBI:27504

object_name: Stage IVB Colorectal Cancer AJCC v8


subject: CHEBI:27504

object_name: Stage IVA Colorectal Cancer AJCC v8


subject: CHEBI:27504

object_name: Stage IV Ovarian Carcinoma


subject: CHEBI:27504

object_name: Clinical Stage IV Gastric Cancer AJCC v8


subject: CHEBI:27504

object_name: Clinical Stage IVA Gastric Cancer AJCC v8


subject: CHEBI:27504

object_name: Clinical Stage IVB Gastric Cancer AJCC v8


subject: CHEBI:27504

object_name: Stage IV Ovarian Cancer AJCC v8


subject: CHEBI:27504

object_name: Stage IVA Ovarian Cancer AJCC v8


subject: CHEBI:27504

object_name: Stage IVB Ovarian Cancer AJCC v8


subject: CHEBI:27504

object_name: Pathologic Stage IV Gastric Cancer AJCC v8


subject: CHEBI:27504

object_name: Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8


subject: CHEBI:27504

object_name: Stage IVB Appendix Carcinoma AJCC v8


subject: CHEBI:27504

object_name: Stage IVA Appendix Carcinoma AJCC v8


subject: CHEBI:27504

object_name: Stage IVC Appendix Carcinoma AJCC v8


subject: CHEBI:27504

object_name: Stage IV Uterine Corpus Cancer AJCC v8


subject: CHEBI:27504

object_name: Stage IVA Uterine Corpus Cancer AJCC v8


subject: CHEBI:27504

object_name: Stage IVB Uterine Corpus Cancer AJCC v8


subject: CHEBI:27504

object_name: uterine cancer


subject: CHEBI:27504

object_name: Metastatic Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: Stage IV Ovarian Carcinoma


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805

object_name: Metastatic Appendix Carcinoma


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IV Appendix Carcinoma AJCC v8


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429

object_name: Clinical Stage IVB Gastric Cancer AJCC v8


subject: UMLS:C1314429

object_name: Stage IV Ovarian Cancer AJCC v8


subject: UMLS:C1314429

object_name: Stage IVA Ovarian Cancer AJCC v8


subject: UMLS:C1314429

object_name: Stage IVB Ovarian Cancer AJCC v8


subject: UMLS:C1314429

object_name: Pathologic Stage IV Gastric Cancer AJCC v8


subject: UMLS:C1314429


subject: UMLS:C1314429

object_name: Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8


subject: UMLS:C1314429


subject: UMLS:C1314429

object_name: Stage IVB Appendix Carcinoma AJCC v8


subject: UMLS:C1314429

object_name: Stage IVA Appendix Carcinoma AJCC v8


subject: UMLS:C1314429

object_name: Stage IVC Appendix Carcinoma AJCC v8


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: CHEBI:6933

subject_name: Midodrine

object_name: Syncope Related to COVID-19


subject: CHEBI:6933

object_name: Syncope, CTCAE 5.0


subject: CHEBI:6933

object_name: Syncope


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:60648

object_name: non-Hodgkin lymphoma


subject: CHEBI:60648

object_name: Adult Non-Hodgkin Lymphoma


subject: CHEBI:60648

object_name: Childhood Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54675776

subject_name: tetracycline


subject: PUBCHEM.COMPOUND:54675776


subject: PUBCHEM.COMPOUND:54675776


subject: PUBCHEM.COMPOUND:54675776


subject: PUBCHEM.COMPOUND:54685734

subject_name: Epitetracycline


subject: PUBCHEM.COMPOUND:54685734


subject: PUBCHEM.COMPOUND:54685734


subject: PUBCHEM.COMPOUND:54685734


subject: UMLS:C1744619

subject_name: Tetracycline Antibiotics


subject: UMLS:C1744619


subject: UMLS:C1744619


subject: UMLS:C1744619


subject: MESH:C000627108

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: UMLS:C4705670


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: hypopharyngeal carcinoma


subject: UMLS:C0879636

subject_name: IMC C225


subject: CHEBI:49668

subject_name: Gefitinib

object_name: cervical cancer


subject: CHEBI:49668

object_name: cervical carcinoma


subject: CHEBI:49668

object_name: ovarian cancer


subject: CHEBI:49668

object_name: ovarian neoplasm


subject: CHEBI:49668

object_name: ovarian carcinoma


subject: CHEBI:49668

object_name: fallopian tube carcinoma


subject: CHEBI:49668

object_name: fallopian tube cancer


subject: CHEBI:49668

object_name: peritoneum cancer


subject: CHEBI:64119

subject_name: Levosulpiride

object_name: dyspepsia


subject: CHEBI:64119

object_name: Dyspepsia, CTCAE


subject: CHEBI:32168

subject_name: Sulpiride


subject: CHEBI:32168


subject: CHEBI:80270

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:80270

object_name: obesity


subject: CHEBI:80270

object_name: Obesity, CTCAE


subject: PUBCHEM.COMPOUND:52943177


subject: PUBCHEM.COMPOUND:52943177


subject: PUBCHEM.COMPOUND:52943177


subject: PR:000008039

subject_name: GATA-type zinc finger protein 1


subject: PR:000008039


subject: PR:000008039


subject: UMLS:C0061355

subject_name: Glucagon-Like Peptide 1


subject: UMLS:C0061355


subject: UMLS:C0061355


subject: UMLS:C4743433

subject_name: onabotulinum toxin A

object_name: migraine


subject: UMLS:C4743433

object_name: migraine with or without aura, susceptibility to, 1


subject: UMLS:C4743433

object_name: headache migraine chronic


subject: CHEBI:50729

subject_name: Mitoxantrone

object_name: prostate neoplasm


subject: UNII:M170940PMI

subject_name: anetumab ravtansine

object_name: Non-small cell lung cancer stage III


subject: UNII:M170940PMI

object_name: Metastatic non-small cell lung cancer


subject: UNII:M170940PMI

object_name: Non-small cell lung cancer stage IIIB


subject: UNII:M170940PMI

object_name: Non-small cell lung cancer stage IIIA


subject: UNII:M170940PMI

object_name: Mesothelin Positive


subject: UMLS:C3273944

subject_name: Anti-mesothelin antibody-drug conjugate BAY 94-9343


subject: UMLS:C3273944


subject: UMLS:C3273944


subject: UMLS:C3273944


subject: UMLS:C3273944


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab


subject: UNII:52CMI0WC3Y


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C0947677

subject_name: Lipiodol

object_name: pancreatic adenocarcinoma


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Overweight


subject: PUBCHEM.COMPOUND:123610

subject_name: Eptifibatide

object_name: acute myocardial infarction


subject: PUBCHEM.COMPOUND:123610

object_name: Acute Myocardial Infarction by ECG Finding


subject: PUBCHEM.COMPOUND:21937662

subject_name: Isavuconazole

object_name: candidemia


subject: PUBCHEM.COMPOUND:21937662

object_name: candidiasis, invasive


subject: PUBCHEM.COMPOUND:21937662

object_name: candidiasis


subject: PUBCHEM.COMPOUND:21937662

object_name: Mycoses


subject: UMLS:C3661275

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:91450

subject_name: Sapanisertib


subject: UNII:VE267FC2UB

subject_name: figitumumab

object_name: small cell lung carcinoma


subject: UMLS:C1707143


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Vomiting, CTCAE


subject: CHEBI:119915

object_name: Vomiting


subject: CHEBI:27732

subject_name: Caffeine

object_name: respiratory failure


subject: CHEBI:27732

object_name: Respiratory Failure, CTCAE


subject: CHEBI:63626

subject_name: Tesamorelin

object_name: Frailty


subject: CHEBI:63626

object_name: HIV-1 infection


subject: UMLS:C1313807


subject: UMLS:C1313807


subject: GTOPDB:5962

subject_name: dovitinib

object_name: neoplasm


subject: GTOPDB:5962

object_name: cancer


subject: CHEBI:27732

object_name: burning mouth syndrome


subject: PR:000004614

subject_name: bile acid-CoA:amino acid N-acyltransferase

object_name: botulism


subject: PR:000004614

object_name: Poisoning caused by Clostridium botulinum toxin


subject: CHEBI:32297

subject_name: Vinpocetine

object_name: diabetic kidney disease


subject: CHEBI:91571


subject: CHEBI:82339

subject_name: Merphalan

object_name: Metastatic malignant neoplasm to vertebral column


subject: CHEBI:82339

object_name: spinal disease


subject: CHEBI:82339

object_name: Spinal Neoplasm


subject: CHEBI:82339

object_name: Intraspinal Neoplasm


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:4027

subject_name: Cyclophosphamide

object_name: malignant neoplasm of esophagus metastatic to bone


subject: CHEBI:4027

object_name: malignant neoplasm of esophagus metastatic to lung


subject: CHEBI:4027

object_name: malignant neoplasm of esophagus metastatic to liver


subject: CHEBI:4027

object_name: recurrent gastric cancer


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: PR:000001151

subject_name: Toll-like receptor 1

object_name: carcinoma of esophagus


subject: PR:000001151

object_name: esophageal cancer


subject: PR:000001151

object_name: Childhood Esophageal Carcinoma


subject: PR:000001151

object_name: neoplasm of esophagus


subject: PR:000001151


subject: PR:000001151


subject: PR:000001151


subject: PR:000001151


subject: PR:000001151

object_name: gastric adenocarcinoma


subject: MESH:C000719587

object_name: interstitial cystitis


subject: MESH:C000719587

object_name: bladder disease


subject: MESH:C000719587

object_name: urinary system disorder


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: plasma cell myeloma


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0678449

subject_name: Cannabis substance

object_name: Inflammation


subject: UMLS:C0678449

object_name: Inflammatory Response


subject: UMLS:C0678449

object_name: Chronic anxiety


subject: UMLS:C0678449

object_name: generalized anxiety


subject: UMLS:C0024808

subject_name: Marihuana


subject: UMLS:C0024808


subject: UMLS:C0024808


subject: UMLS:C0024808


subject: UMLS:C4552088

subject_name: Cannabis sativa whole extract


subject: UMLS:C4552088


subject: UMLS:C4552088


subject: UMLS:C4552088


subject: CHEBI:4856

subject_name: Esmolol

object_name: Severe Sepsis


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: chronic rhinosinusitis


subject: GTOPDB:12969

subject_name: tarlatamab

object_name: pancreatic endocrine carcinoma


subject: GTOPDB:12969

object_name: Neuroendocrine carcinoma of pancreas


subject: GTOPDB:12969

object_name: Neuroendocrine carcinoma of prostate


subject: UNII:74X82ST8Q1

subject_name: TARLATAMAB


subject: UNII:74X82ST8Q1


subject: UNII:74X82ST8Q1


subject: UMLS:C4687660

subject_name: AMG 757


subject: UMLS:C4687660


subject: UMLS:C4687660


subject: UMLS:C0305578

subject_name: Centrum

object_name: keratoconus


subject: CHEBI:10127

subject_name: Zonisamide

object_name: post-traumatic stress disorder


subject: CHEBI:173763

subject_name: Thermophillin


subject: PUBCHEM.COMPOUND:23597337

subject_name: Physalin L


subject: CHEBI:4659

subject_name: Disulfiram


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Global Relapse in Viscera


subject: UNII:2S9ZZM9Q9V

object_name: Global Relapse in Lymph Nodes


subject: UNII:2S9ZZM9Q9V

object_name: Relapse Following Intervention for Kawasaki Disease


subject: UNII:2S9ZZM9Q9V

object_name: Global Relapse


subject: UNII:2S9ZZM9Q9V

object_name: Global Relapse in Skin


subject: UNII:2S9ZZM9Q9V

object_name: Global Relapse in Blood


subject: CHEBI:83766

subject_name: Olaparib


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: UNII:28X28X9OKV

subject_name: Durvalumab


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: PR:000022283

subject_name: excinuclease cho

object_name: Acute phase response


subject: PR:000022283

object_name: type 2 diabetes mellitus


subject: PR:000022283

object_name: Insulin resistance


subject: PR:000022283

object_name: Ketosis


subject: PR:000022283

object_name: Ketoacidosis


subject: UniProtKB:P76213

subject_name: CHO_ECOLI Excinuclease cho (sprot)


subject: UniProtKB:P76213


subject: UniProtKB:P76213


subject: UniProtKB:P76213


subject: UniProtKB:P76213


subject: CHEBI:141449

subject_name: Trp-Pro


subject: CHEBI:141449


subject: CHEBI:141449


subject: CHEBI:141449


subject: CHEBI:141449


subject: CHEBI:8863

subject_name: Riluzole

object_name: Inflammation


subject: CHEBI:8863

object_name: Fatigue, CTCAE 5.0


subject: CHEBI:8863

object_name: Fatigue


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: ischemia


subject: PUBCHEM.COMPOUND:4715169

object_name: Rest limb pain


subject: PUBCHEM.COMPOUND:4715169

object_name: peripheral vascular disease


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:64356


subject: CHEBI:64356


subject: UNII:9CXQ3PF69U

subject_name: Imlunestrant

object_name: Childhood Breast Carcinoma


subject: UNII:9CXQ3PF69U

object_name: breast carcinoma


subject: UNII:9CXQ3PF69U

object_name: breast cancer


subject: UMLS:C5706403

subject_name: Mutant-selective PI3K-alpha H1047R Inhibitor LOXO-783


subject: UMLS:C5706403


subject: UMLS:C5706403


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: anal canal cancer


subject: UNII:52CMI0WC3Y

object_name: anal canal carcinoma


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C4329512

subject_name: UCPVax

object_name: cervical cancer


subject: UMLS:C4329512

object_name: cervical carcinoma


subject: UMLS:C4329512


subject: UMLS:C4329512


subject: UMLS:C4329512

object_name: head and neck squamous cell carcinoma


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Neoplasms by Histologic Type


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:149837

subject_name: Alisporivir

object_name: chronic pain (diagnosis)


subject: CHEBI:149837

object_name: Chronic pain


subject: UMLS:C1567950

subject_name: alisporivir


subject: UMLS:C1567950


subject: PUBCHEM.COMPOUND:4689

subject_name: Paromomycin I

object_name: Leishmaniasis, New World


subject: CHEBI:7934

subject_name: Paromomycin


subject: CHEBI:50692

subject_name: Mifepristone

object_name: bipolar depression


subject: UMLS:C0701303

object_name: bipolar disorder


subject: UMLS:C0701303


subject: PR:000034030

subject_name: FMN reductase (NADH) RutF

object_name: Wasting


subject: PR:000034030

object_name: Cachexia


subject: CHEBI:131527

subject_name: Dipotassium phosphate

object_name: hypoglycemia


subject: CHEBI:131527

object_name: Blood glucose below reference range (finding)


subject: CHEBI:131527

object_name: Hypoglycemia, CTCAE


subject: CHEBI:190301


subject: CHEBI:190301


subject: CHEBI:190301


subject: CHEBI:63036


subject: CHEBI:63036


subject: CHEBI:63036


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: polyostotic fibrous dysplasia


subject: UNII:I031V2H011

object_name: McCune-Albright syndrome


subject: UNII:I031V2H011

object_name: fibrous dysplasia


subject: MESH:C000711077

object_name: Childhood Breast Carcinoma


subject: MESH:C000711077

object_name: breast carcinoma


subject: MESH:C000711077

object_name: breast cancer


subject: MESH:C000711077

object_name: neoplasm


subject: UMLS:C3896787


subject: UMLS:C3896787


subject: UMLS:C3896787


subject: UMLS:C3896787


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: Chronic Myelomonocytic Leukemia-2


subject: CHEBI:28680

subject_name: Cytarabine


subject: UMLS:C0064865

subject_name: levanase

object_name: Propensity to adverse reactions to food (finding)


subject: UMLS:C0064865

object_name: Food intolerance


subject: CHEBI:60799

subject_name: Esketamine

object_name: Sedation complication


subject: MESH:C000627770

subject_name: folfirinox

object_name: Stomach cancer


subject: MESH:C000627770

object_name: gastric cancer


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: Insulin Sensitivity


subject: UMLS:C1136254

subject_name: Microbicides

object_name: osteomyelitis


subject: UMLS:C5399717

subject_name: Antimicrobial [APC]


subject: UNII:696R5N4NRM

object_name: rheumatoid arthritis


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: extranodal nasal NK/T cell lymphoma


subject: UNII:3A189DH42V

object_name: angioimmunoblastic T-cell lymphoma


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: Functional disorder


subject: UMLS:C3658854


subject: CHEBI:192761

subject_name: Iron sucrose

object_name: non-Hodgkin lymphoma


subject: CHEBI:192761

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:192761

object_name: plasma cell myeloma


subject: CHEBI:29033

subject_name: Ferrous cation


subject: CHEBI:29033


subject: CHEBI:29033


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: post-traumatic stress disorder


subject: CHEBI:52993

subject_name: Lormetazepam

object_name: Critical Illness


subject: CHEBI:6539

subject_name: Lorazepam


subject: UNII:3A3U0GI71G

subject_name: Magnesium oxide

object_name: Androgen excess


subject: CHEBI:31794

subject_name: magnesium oxide


subject: UNII:7D0YB67S97

subject_name: Abatacept

object_name: inflammatory spondylopathy


subject: UMLS:C0378942


subject: CHEBI:95341

subject_name: Baricitinib

object_name: psoriatic arthritis


subject: CHEBI:95341


subject: UMLS:C2959235

subject_name: Injection, canakinumab, 1 mg administered


subject: UMLS:C2959235


subject: UMLS:C2959235


subject: UMLS:C5203516

subject_name: Canakinumab Liquid Injection


subject: UMLS:C5203516


subject: UMLS:C5203516


subject: UNII:37CQ2C7X93

subject_name: Canakinumab


subject: UNII:37CQ2C7X93


subject: UNII:BTY153760O

subject_name: Ixekizumab


subject: UNII:BTY153760O


subject: UNII:DLG4EML025

subject_name: Secukinumab


subject: UMLS:C3537192

subject_name: Tumor Necrosis Factor Inhibitors


subject: UMLS:C3537192


subject: UNII:4RA0KN46E0

subject_name: Upadacitinib


subject: CHEBI:135697

subject_name: Sarpogrelate

object_name: stroke disorder


subject: CHEBI:135697

object_name: cerebral infarction


subject: CHEBI:135697

object_name: cerebrovascular disorder


subject: UMLS:C0083358


subject: UMLS:C0083358


subject: UMLS:C0083358


subject: UMLS:C1313726

object_name: lung cancer


subject: UMLS:C1313726

object_name: lung neoplasm


subject: UMLS:C1313726

object_name: lung carcinoma


subject: UMLS:C1313726

object_name: Childhood Breast Carcinoma


subject: UMLS:C1313726

object_name: breast carcinoma


subject: UMLS:C1313726

object_name: breast cancer


subject: UMLS:C1313726

object_name: renal carcinoma


subject: UMLS:C1313726

object_name: kidney neoplasm


subject: UMLS:C1313726

object_name: kidney cancer


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Fusion of spine, lumbar region


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: CHEBI:74705

subject_name: Met-Leu


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Emergence from anesthesia


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:87647

subject_name: tolonium chloride

object_name: Atrophy of alveolar ridges


subject: CHEBI:87647

object_name: periodontitis, chronic, adult


subject: CHEBI:87647

object_name: chronic periodontitis


subject: CHEBI:87647

object_name: periodontal disorder


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: ovarian cancer


subject: GTOPDB:9592

object_name: ovarian neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: PUBCHEM.COMPOUND:56971685

subject_name: Relebactam

object_name: urinary tract infection


subject: PUBCHEM.COMPOUND:56971685

object_name: Recurrent urinary tract infections


subject: PUBCHEM.COMPOUND:56971685

object_name: pyelonephritis


subject: CHEBI:24621

subject_name: hormone

object_name: mild neurocognitive disorder


subject: CHEBI:24621

object_name: mild cognitive impairment


subject: CHEBI:24621

object_name: Mild dementia


subject: UNII:NQ99E8OH3P

subject_name: Rilematovir

object_name: Hepatic impairment


subject: UMLS:C4549198


subject: CHEBI:73579

subject_name: Leu-Val

object_name: colorectal neoplasm


subject: CHEBI:194537

subject_name: Livermorium


subject: UMLS:C1881413

subject_name: Liposome Vesicle


subject: PR:000003915

subject_name: delta-aminolevulinic acid dehydratase


subject: UMLS:C1522140


subject: UMLS:C5787220

subject_name: HM15211 (LONG-ACTING GLP-1/GIP/GLUCAGON TRIPLE AGONIST)


subject: MESH:C000851

subject_name: flupentixol, melitracen drug combination

object_name: dyspepsia


subject: MESH:C000851

object_name: Dyspepsia, CTCAE


subject: MESH:C000851

object_name: Pulmonary compliance


subject: MESH:C000851

object_name: Depressed mood


subject: MESH:C000851

object_name: Cancer patients and suicide and depression


subject: MESH:C000851

object_name: Depressed - symptom


subject: MESH:C000851

object_name: Depression, CTCAE


subject: CHEBI:73907

subject_name: Gly-Ile


subject: CHEBI:73907


subject: CHEBI:73907


subject: CHEBI:73907


subject: CHEBI:73907


subject: CHEBI:73907


subject: CHEBI:73907


subject: CHEBI:7772

subject_name: omeprazole


subject: CHEBI:77260

subject_name: Omeprazole


subject: UMLS:C0718234

subject_name: Acthar

object_name: psoriatic arthritis


subject: UMLS:C3540795

subject_name: ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS

object_name: Early Stage Breast Carcinoma


subject: PUBCHEM.COMPOUND:284240

object_name: adult lymphoma


subject: PUBCHEM.COMPOUND:284240

object_name: lymphoma


subject: PUBCHEM.COMPOUND:284240

object_name: pediatric lymphoma


subject: PUBCHEM.COMPOUND:284240

object_name: cancer


subject: PUBCHEM.COMPOUND:284240

object_name: neoplasm


subject: PUBCHEM.COMPOUND:284240

object_name: Childhood Solid Neoplasm


subject: PUBCHEM.COMPOUND:284240

object_name: Adult Solid Neoplasm


subject: PUBCHEM.COMPOUND:284240

object_name: Solid Neoplasm


subject: UNII:2X1K91UT6N

subject_name: Alovudine F-18


subject: UNII:2X1K91UT6N


subject: UNII:2X1K91UT6N


subject: UNII:2X1K91UT6N


subject: UNII:2X1K91UT6N


subject: UNII:2X1K91UT6N


subject: UNII:2X1K91UT6N


subject: UNII:2X1K91UT6N


subject: GTOPDB:9107

subject_name: cabiralizumab

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: UNII:5FJL6W0640

subject_name: CABIRALIZUMAB


subject: UMLS:C4085968


subject: UMLS:C4528719

object_name: alveolar soft part sarcoma


subject: UMLS:C4528719

object_name: Childhood Synovial Sarcoma


subject: UMLS:C4528719

object_name: Adult Synovial Sarcoma


subject: UMLS:C4528719

object_name: synovial sarcoma


subject: UMLS:C4528719

object_name: leiomyosarcoma


subject: UMLS:C4528719

object_name: Childhood Leiomyosarcoma


subject: UMLS:C4528719

object_name: Adult Leiomyosarcoma


subject: GTOPDB:13716

subject_name: disitamab vedotin


subject: GTOPDB:13716


subject: GTOPDB:13716


subject: UNII:RB3U3A1S27

subject_name: DISITAMAB VEDOTIN


subject: UNII:RB3U3A1S27


subject: UNII:RB3U3A1S27


subject: UMLS:C4329329


subject: UMLS:C4329329


subject: UMLS:C4329329


subject: CHEBI:37084

subject_name: beta-Hydroxyisovaleric acid

object_name: bronchiectasis


subject: CHEBI:73915

subject_name: Gly-Phe-Phe

object_name: chronic obstructive pulmonary disease


subject: CHEBI:167574

subject_name: Semaglutide

object_name: infertility


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: Surgical wound, healed


subject: CHEBI:150712

object_name: Impacted third molar tooth


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: CHEMBL.COMPOUND:CHEMBL5314376


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: lumbar disk disease


subject: CHEBI:62088

subject_name: Metamizole


subject: CHEBI:62088

object_name: lumbar disk degenerative disorder


subject: CHEBI:75722

subject_name: Tramadol


subject: CHEBI:75722


subject: UMLS:C0919075

subject_name: INJECTION, ZIDOVUDINE, 10 MG ADMINISTERED

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C0919075

object_name: non-Hodgkin lymphoma


subject: CHEBI:10110

subject_name: Zidovudine


subject: CHEBI:10110


subject: UMLS:C0598695

subject_name: NMDA receptor antagonist

object_name: borderline personality disorder


subject: UMLS:C3536824

subject_name: N-methyl-D-aspartate Receptor Antagonist [EPC]


subject: MESH:D003287

subject_name: Contrast Media

object_name: epilepsy


subject: MESH:D003287

object_name: Headache


subject: MESH:D003287

object_name: Headache, CTCAE


subject: MESH:D003287

object_name: dizziness


subject: MESH:D003287

object_name: Dizziness, CTCAE 5.0


subject: MESH:D003287

object_name: Dizziness, CTCAE 3.0


subject: CHEBI:60799

subject_name: Esketamine

object_name: Osteochondritis


subject: CHEBI:60799

object_name: Compulsion


subject: CHEBI:60799


subject: CHEBI:17234

subject_name: D-glucose

object_name: Hyperglycemia, CTCAE


subject: CHEBI:17234

object_name: Glucose in blood specimen above reference range


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: hyperglycemia


subject: CHEBI:9130


subject: CHEBI:9130


subject: CHEBI:9150

subject_name: Simvastatin


subject: CHEBI:9150


subject: CHEBI:9150


subject: CHEBI:38290

subject_name: L-ascorbate


subject: CHEBI:38290


subject: CHEBI:38290


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C5557949

subject_name: Streptococcus pneumoniae Danish serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F, and 33F capsular polysaccharide conjugated antigens only vaccine product

object_name: pneumococcal infection


subject: UMLS:C0305062

subject_name: Tetanus Toxoid


subject: UMLS:C0982332

subject_name: acellular pertussis vaccine, inactivated


subject: UMLS:C1179435

subject_name: Protein Component


subject: MESH:D017778

subject_name: Vaccines, Combined


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: glomerulonephritis


subject: CHEBI:151315

subject_name: Heparin

object_name: Disseminated Intravascular Coagulation Related to COVID-19


subject: CHEBI:151315

object_name: disseminated intravascular coagulation


subject: CHEBI:151315

object_name: Disseminated Intravascular Coagulation, CTCAE


subject: CHEBI:230519

subject_name: heparin sodium

object_name: Sepsis


subject: CHEBI:230519

object_name: Sepsis, CTCAE


subject: CHEBI:230519


subject: CHEBI:230519


subject: CHEBI:230519


subject: CHEBI:47426

subject_name: Furosemide

object_name: Renal Failure, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL4594472

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594472

object_name: Advanced Lung Non-Small Cell Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594472

object_name: Stage IV Lung Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL4594472

object_name: Stage IVA Lung Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL4594472

object_name: Stage IVB Lung Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL4594472

object_name: Stage III Lung Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL4594472

object_name: EGFR mutation-related tumors


subject: CHEMBL.COMPOUND:CHEMBL4594472

object_name: Stage IIIA Lung Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL4594472

object_name: Stage IIIB Lung Cancer AJCC v8


subject: UMLS:C4764036


subject: UMLS:C4764036


subject: UMLS:C4764036


subject: UMLS:C4764036


subject: UMLS:C4764036


subject: UMLS:C4764036


subject: UMLS:C4764036


subject: UMLS:C4764036


subject: UMLS:C4764036


subject: CHEBI:90943

subject_name: Osimertinib


subject: UMLS:C1872514

subject_name: talactoferrin alfa

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C1872514

object_name: salivary gland squamous cell carcinoma


subject: UMLS:C1872514

object_name: Neck Squamous Cell Carcinoma of Unknown Primary


subject: UMLS:C1872514

object_name: recurrent metastatic squamous neck cancer with occult primary


subject: UMLS:C1872514

object_name: Laryngeal squamous cell carcinoma recurrent


subject: UMLS:C1872514

object_name: tongue cancer


subject: UMLS:C1872514

object_name: tongue carcinoma


subject: UMLS:C1872514

object_name: stage IVB squamous cell carcinoma of the larynx


subject: UMLS:C1872514

object_name: Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C1872514

object_name: stage IVA squamous cell carcinoma of the larynx


subject: UMLS:C1872514

object_name: Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C1872514

object_name: Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C1872514

object_name: stage IVC squamous cell carcinoma of the larynx


subject: UMLS:C1872514

object_name: Laryngeal squamous cell carcinoma stage III


subject: UMLS:C1872514

object_name: Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: UMLS:C1872514

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: UMLS:C1872514

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: UMLS:C1872514

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: UMLS:C1872514

object_name: Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C1872514

object_name: stage IVB squamous cell carcinoma of the oropharynx


subject: UMLS:C1872514

object_name: stage IVC squamous cell carcinoma of the oropharynx


subject: UMLS:C1872514

object_name: Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C1872514

object_name: Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C1872514

object_name: stage IVA squamous cell carcinoma of the oropharynx


subject: UMLS:C1872514

object_name: Oropharyngeal squamous cell carcinoma stage III


subject: UMLS:C1872514

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: UMLS:C1872514

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C1872514

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: UMLS:C1872514

object_name: Nasopharyngeal squamous cell carcinoma stage III


subject: UMLS:C1872514

object_name: Hypopharyngeal squamous cell carcinoma stage III


subject: UMLS:C1872514

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: UMLS:C1872514

object_name: stage IVB squamous cell carcinoma of the lip and oral cavity


subject: UMLS:C1872514

object_name: stage IVC squamous cell carcinoma of the lip and oral cavity


subject: UMLS:C1872514

object_name: stage IVA squamous cell carcinoma of the lip and oral cavity


subject: UMLS:C1872514

object_name: Stage III Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UMLS:C1872514

object_name: Recurrent Sinonasal Squamous Cell Carcinoma


subject: UMLS:C1872514

object_name: stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: UMLS:C1872514

object_name: stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: UMLS:C1872514

object_name: stage III squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: UMLS:C1872514

object_name: stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: UMLS:C1872514

object_name: Recurrent Salivary Gland Cancer


subject: UMLS:C1872514

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: UMLS:C1872514

object_name: Laryngeal verrucous carcinoma recurrent


subject: UMLS:C1872514

object_name: Stage IVB Major Salivary Gland Cancer AJCC v7


subject: UMLS:C1872514

object_name: stage IVB salivary gland cancer


subject: UMLS:C1872514

object_name: stage IVC salivary gland cancer


subject: UMLS:C1872514

object_name: Stage IVC Major Salivary Gland Cancer AJCC v7


subject: UMLS:C1872514

object_name: Stage IVA Major Salivary Gland Cancer AJCC v7


subject: UMLS:C1872514

object_name: stage IVA salivary gland cancer


subject: UMLS:C1872514

object_name: Salivary gland cancer stage III


subject: UMLS:C1872514

object_name: Stage III Major Salivary Gland Cancer AJCC v7


subject: UMLS:C1872514

object_name: Verrucous carcinoma of the oral cavity stage III


subject: UMLS:C1872514

object_name: Stage IVA Oral Cavity Verrucous Carcinoma


subject: UMLS:C1872514

object_name: Stage IVB Oral Cavity Verrucous Carcinoma


subject: UMLS:C1872514

object_name: Stage IVC Oral Cavity Verrucous Carcinoma


subject: UMLS:C1872514

object_name: Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7


subject: UMLS:C1872514

object_name: Laryngeal verrucous carcinoma stage III


subject: UMLS:C1872514

object_name: Stage IVA Laryngeal Verrucous Carcinoma AJCC v7


subject: UMLS:C1872514

object_name: stage IVA verrucous carcinoma of the larynx


subject: UMLS:C1872514

object_name: Stage IVB Laryngeal Verrucous Carcinoma AJCC v7


subject: UMLS:C1872514

object_name: stage IVB verrucous carcinoma of the larynx


subject: UMLS:C1872514

object_name: Stage IVC Laryngeal Verrucous Carcinoma AJCC v7


subject: UMLS:C1872514

object_name: stage IVC verrucous carcinoma of the larynx


subject: UNII:T21N67B1V3

object_name: head and neck squamous cell carcinoma


subject: UNII:T21N67B1V3

object_name: esophageal squamous cell carcinoma


subject: UNII:T21N67B1V3

object_name: Childhood Breast Carcinoma


subject: UNII:T21N67B1V3

object_name: breast carcinoma


subject: UNII:T21N67B1V3

object_name: breast cancer


subject: UMLS:C5236067

subject_name: SHP2 Inhibitor JAB-3312


subject: UMLS:C5236067


subject: UMLS:C5236067


subject: UMLS:C5236067


subject: UMLS:C5236067


subject: UMLS:C5205926

subject_name: Zeluvalimab

object_name: small cell lung carcinoma


subject: CHEBI:135933

subject_name: Tin Fluorides

object_name: Skin plaque


subject: CHEBI:135933

object_name: Senile plaques


subject: CHEBI:135933

object_name: Plaque (lesion)


subject: CHEBI:7986

object_name: hepatorenal syndrome


subject: CHEBI:50659

subject_name: Dronedarone

object_name: atrial flutter


subject: CHEBI:50659

object_name: Atrial Flutter by ECG Finding


subject: CHEBI:50659

object_name: Atrial Flutter, CTCAE


subject: CHEBI:6413

subject_name: Letrozole

object_name: Transsexual (finding)


subject: CHEBI:6413

object_name: Transgender


subject: UNII:19ORU63E06

object_name: adult lymphoma


subject: UNII:19ORU63E06

object_name: lymphoma


subject: UNII:19ORU63E06

object_name: pediatric lymphoma


subject: UMLS:C5237268

subject_name: Gallium Ga 68 FAPi-46

object_name: Malignant melanoma stage IV


subject: UMLS:C5926468

subject_name: FAPi-46 GA-68


subject: UMLS:C3896791

subject_name: IDH1R132H-Specific Peptide Vaccine PEPIDH1M

object_name: Low grade glioma of brain


subject: UNII:789Q85GA8P

subject_name: Vorasidenib


subject: DRUGBANK:DB11360

subject_name: Lactobacillus plantarum

object_name: chronic pain (diagnosis)


subject: DRUGBANK:DB11360

object_name: Chronic pain


subject: CHEBI:36005

subject_name: docosahexaenoic acid

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: CHEBI:36005

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: CHEBI:36005

object_name: Stage IA Breast Cancer AJCC v7


subject: CHEBI:36005

object_name: stage IA breast cancer


subject: CHEBI:36005

object_name: breast benign neoplasm


subject: CHEBI:36005

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: CHEBI:36005

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: CHEBI:36005

object_name: Stage IB Breast Cancer AJCC v7


subject: CHEBI:36005

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:36005

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:36005

object_name: Stage IIA Breast Carcinoma


subject: CHEBI:36005

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:36005

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:36005

object_name: Stage IIB Breast Carcinoma


subject: CHEBI:36005

object_name: malignant neoplasm of breast stage IIb


subject: CHEBI:36005

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:36005

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:36005

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:36005

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:36005

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:36005

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:36005

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:36005

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:36005

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:36005

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:36005

object_name: invasive breast carcinoma


subject: CHEBI:36005

object_name: mammary Paget disease


subject: CHEBI:36005

object_name: Paget disease of the nipple


subject: CHEBI:36005

object_name: ductal breast carcinoma in situ


subject: CHEBI:36005

object_name: lobular breast carcinoma in situ


subject: CHEBI:28125

subject_name: Doconexent

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: CHEBI:28125

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: CHEBI:28125

object_name: Stage IA Breast Cancer AJCC v7


subject: CHEBI:28125

object_name: stage IA breast cancer


subject: CHEBI:28125

object_name: breast benign neoplasm


subject: CHEBI:28125

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: CHEBI:28125

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: CHEBI:28125

object_name: Stage IB Breast Cancer AJCC v7


subject: CHEBI:28125

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:28125

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:28125

object_name: Stage IIA Breast Carcinoma


subject: CHEBI:28125

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:28125

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:28125

object_name: Stage IIB Breast Carcinoma


subject: CHEBI:28125

object_name: malignant neoplasm of breast stage IIb


subject: CHEBI:28125

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:28125

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:28125

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:28125

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:28125

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:28125

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:28125

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:28125

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:28125

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:28125

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:28125

object_name: invasive breast carcinoma


subject: CHEBI:28125

object_name: mammary Paget disease


subject: CHEBI:28125

object_name: Paget disease of the nipple


subject: CHEBI:28125

object_name: ductal breast carcinoma in situ


subject: CHEBI:28125

object_name: lobular breast carcinoma in situ


subject: UNII:PA05MFH3I7

object_name: acute myeloid leukemia by FAB classification


subject: UNII:PA05MFH3I7

object_name: acute myeloid leukemia


subject: UMLS:C4691285

subject_name: lamivudine-tenofovir 300 mg-300 mg oral tablet

object_name: sexually transmitted disease


subject: UMLS:C4691285

object_name: HIV infection


subject: CHEBI:8665

subject_name: Pyridostigmine

object_name: Gastrointestinal motility disorder


subject: CHEBI:8665

object_name: change of transit or circulation


subject: CHEBI:8665

object_name: diabetic autonomic neuropathy


subject: UMLS:C1135137

object_name: renal carcinoma


subject: UMLS:C1135137

object_name: kidney neoplasm


subject: UMLS:C1135137

object_name: kidney cancer


subject: CHEBI:134726

subject_name: Istradefylline

object_name: Hepatic impairment


subject: CHEBI:31348

subject_name: Capecitabine

object_name: CNS metastases


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: male breast carcinoma


subject: PUBCHEM.COMPOUND:70789204


subject: CHEBI:31348

object_name: Renal cell carcinoma recurrent


subject: CHEBI:31348

object_name: Stage III Renal Cell Cancer AJCC v7


subject: CHEBI:31348

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:175901


subject: PUBCHEM.COMPOUND:49863420

subject_name: ceftolozane

object_name: Critical Illness


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: Metastatic Malignant Solid Neoplasm


subject: UMLS:C1530450

subject_name: AMG 162


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: head and neck neoplasm


subject: UNII:CC3QFH9UUA

object_name: premature ejaculation


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: autism spectrum disorder


subject: CHEBI:91398

subject_name: Tivantinib

object_name: hormone-resistant prostate carcinoma


subject: CHEBI:91398

object_name: Stage IV Prostate Cancer AJCC v6


subject: CHEBI:91398

object_name: Carcinoma of the prostate stage IV


subject: CHEBI:91398

object_name: Stage IV Prostate Cancer AJCC v7


subject: CHEBI:91398

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:91398

object_name: Prostate cancer recurrent


subject: CHEBI:91398

object_name: prostate adenocarcinoma


subject: CHEBI:17087

subject_name: ketone

object_name: Metabolic ketoacidosis